Equity (Tables)

3 Months Ended

Mar. 31, 2017

Equity [Abstract]

Schedule of Common Stock Granted

During the three months ended March 31, 2017 and 2016, the Company granted common shares to certain employees and trustees as follows:

	Three Months ended March 31,
	2017	2016
Performance Shares(1)
Shares granted:
Index	106,706	404,466
Peer	106,705	404,463
Grant date fair value per share:(2)
Index	$6.82	$4.53
Peer	$6.34	$4.58
Non-Vested Common Shares:(3)
Shares issued	237,560	225,090
Grant date fair value	$2,551	$1,724
Non-management Board of Trustee grant:(4)
Shares issued	17,500	17,500
Grant date fair value	$190	$131

(1) The shares vest based on the Company's total shareholder return growth after a three-year measurement period relative to an index and a group of Company peers. Dividends will not be paid on these grants until earned. Once the performance criteria are met and the actual number of shares earned is determined, such shares vest immediately. During the three months ended March 31, 2017, the Company issued an additional 326,929 performance shares, which are subject to shareholder approval.

(2) The fair value of grants was determined at the grant date using a Monte Carlo simulation model.

(3) The shares vest ratably over a three-year service period.

(4) Annual grant and shares vested upon grant.

Schedule of Accumulated Other Comprehensive Income (Loss)

A summary of the changes in accumulated other comprehensive income (loss) related to the Company's cash flow hedges is as follows:

	Three Months ended March 31,
	2017			2016
Balance at beginning of period	$	(1,033	)	$	(1,939	)
Other comprehensive income (loss) before reclassifications	688			(5,691		)
Amounts of loss reclassified from accumulated other comprehensive income to interest expense	604			1,066
Balance at end of period	$	259		$	(6,564	)